Weight loss drugs can halve heart patients’ risk of early death, study finds
The article discusses a study that found weight loss drugs, specifically GLP-1 agonists, can significantly reduce the risk of early death and hospitalization for heart patients. The study, which was the largest of its kind, showed that these drugs could potentially be given to millions of people with heart conditions to help them stay out of the hospital and live longer. The drugs were found to cut the risk of heart patients being hospitalized or dying prematurely from any cause by up to 50%. The article highlights the "dramatic benefits" of these weight loss drugs for heart patients, suggesting they could be a valuable tool in improving outcomes for this population.
Source: For the complete article, please visit the original source link below.
